| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 04/06/2005 | EP1519961A1 Low molecular weight oversulfated polysaccharide |
| 04/06/2005 | EP1519960A2 Mutant fab fragments of the chimeric 13b8.2 anti-cd4 antibody and uses thereof |
| 04/06/2005 | EP1519956A2 Epha2 monoclonal antibodies and methods of use thereof |
| 04/06/2005 | EP1519952A1 Use of aspartic proteases in cosmetics and therapeutics |
| 04/06/2005 | EP1519922A1 Di-aryl-substituted ethane pyridone pde4 inhibitors |
| 04/06/2005 | EP1519915A2 Tricyclic steroid hormone nuclear receptor modulators |
| 04/06/2005 | EP1519908A2 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof |
| 04/06/2005 | EP1519754A1 Use of cetp inhibitors and optionally hmg coa reductase inhibitors and/or antihypertensive agents |
| 04/06/2005 | EP1519749A1 Chemotactic factor inhibitor for modulating inflammatory reactions |
| 04/06/2005 | EP1519733A1 Compositions for cancer therapy comprising saponins or sapogenins |
| 04/06/2005 | EP1519730A1 Novel use of imidazotriazinones |
| 04/06/2005 | EP1519724A1 Fredericamycin derivatives as medicaments for treating tumours |
| 04/06/2005 | EP1519722A1 Glycoloyl-substituted oxazolidinone-derivatives as antibacterial agents |
| 04/06/2005 | EP1519707A1 Method and composition for improving sensory characteristics of semisolid predominantly anhydrous lipids |
| 04/06/2005 | EP1406898B1 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| 04/06/2005 | EP1353909B1 8-substituted-2,6-methano-3-benzazocines and 3-substituted morphinanes as opioidreceptor binding agents |
| 04/06/2005 | EP1307455B1 Inhibitors of alpha-l beta-2 mediated cell adhesion |
| 04/06/2005 | EP1212100B1 Delivery system for antidandruff agent |
| 04/06/2005 | EP1100529B1 Thymosin beta 4 promotes wound repair |
| 04/06/2005 | EP0988029B1 Device and methods for wound treatment |
| 04/06/2005 | EP0944310B1 Stabilized ascorbyl compositions |
| 04/06/2005 | EP0748219B1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 04/06/2005 | CN2689944Y Chitosan medical film wound plaster |
| 04/06/2005 | CN1604909A Cyclic peptides as g-protein-coupled receptor antagonists |
| 04/06/2005 | CN1604904A Phosphonic acid compounds as inhibitors of serine proteases |
| 04/06/2005 | CN1604901A Bicyclic oxopyridine and oxopyrimidine derivatives |
| 04/06/2005 | CN1604898A 3-heteroaryl-3, 5-dihydro-4-oxo-4h-pyridazino[4, 5-b]indole-1-carboxamide derivatives, their preparation, their intermediates and pharmaceutical compositions containing the compounds |
| 04/06/2005 | CN1604793A Methods of treatment and formulations of cephalosporin |
| 04/06/2005 | CN1604779A Novel methods of treating local fungal and bacterial infections |
| 04/06/2005 | CN1604772A Transdermal transport of compounds |
| 04/06/2005 | CN1603342A Caspase-8 interacting proteins |
| 04/06/2005 | CN1603263A Use of glass compositions for achieving an antioxidative effect |
| 04/06/2005 | CN1602956A Deactivated BCG for treating disease |
| 04/06/2005 | CN1602937A Beautifying and climacteric syndrome treating composition, its preparing process and usage |
| 04/06/2005 | CN1602928A Medicine for treating burn and scald and its preparation process |
| 04/06/2005 | CN1602927A Wind expelling, toxin removing bone reaching powder |
| 04/06/2005 | CN1602922A Externally applied Chinese traditional medicinal wine and its preparing method |
| 04/06/2005 | CN1602908A Scald treating ointment |
| 04/06/2005 | CN1602904A Chinese traditional medicinal preparation for treating acne and whelk |
| 04/06/2005 | CN1602895A Trauma treating drug |
| 04/06/2005 | CN1602892A Nutrient fluid for treating ultraviolet allergy |
| 04/06/2005 | CN1602866A Dripping pills of tripelennamine hydrochloride and its preparation method |
| 04/06/2005 | CN1602863A Dripping pills of furazabol and its preparation method |
| 04/06/2005 | CN1602860A Dripping pills of clemastine fumarate and its preparation method |
| 04/06/2005 | CN1602859A Dripping pills of methoxsalen and its preparation method |
| 04/06/2005 | CN1602841A Immuno-modulatory agents administration form for whole body or local immunity disorder |
| 04/06/2005 | CN1602839A Long-lasting water proof and wearable leukoderma covering agent |
| 04/06/2005 | CN1195778C Cell adhension inhibitors |
| 04/06/2005 | CN1195773C Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 04/06/2005 | CN1195755C Pyrrolo [2, 3-d] pyrimidine compounds |
| 04/06/2005 | CN1195513C Tocopherols, tocotrienols, other chroman and side chain derivatives and uses |
| 04/06/2005 | CN1195512C Use of fatty materials for prevention or reduction of microorganism adherence on skin and/or mucous membrane |
| 04/06/2005 | CN1195490C Skin-care composition |
| 04/06/2005 | CN1195489C Seabuckthorn essence concentrate |
| 04/06/2005 | CN1195475C 化学去皮剂 Chemical peeling agents |
| 04/06/2005 | CN1195415C Topical, non-cytotoxic, antimicrobial hydrogel with thixotropic properties |
| 04/05/2005 | US6875868 Pteridine compounds for the treatment of psoriasis |
| 04/05/2005 | US6875846 Heterologous polypeptide of the TNF family |
| 04/05/2005 | US6875789 Pyrazole-derived kinase inhibitors and uses thereof |
| 04/05/2005 | US6875779 Cyclooxygenase inhibitor |
| 04/05/2005 | US6875767 (5-cyano-2-thiazolyl)amino-4-pyridine tyrosine kinase inhibitors |
| 04/05/2005 | US6875757 LPA receptor agonists and antagonists and methods of use |
| 04/05/2005 | US6875736 Methods for identifying RNA binding compounds |
| 04/05/2005 | US6875570 Proteins and nucleic acids encoding same |
| 03/31/2005 | WO2005028463A1 Cinnamoyl compound and use of the same |
| 03/31/2005 | WO2005028455A1 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient |
| 03/31/2005 | WO2005028454A1 Haloalkyl containing compounds as cysteine protease inhibitors |
| 03/31/2005 | WO2005028441A1 Cinnamoyl derivatives and use thereof |
| 03/31/2005 | WO2005028439A1 Cinnamoyl compound and use of the same |
| 03/31/2005 | WO2005028426A1 Novel 4-phenylamino-benzaldoxime derivative and use thereof as mek inhibitor |
| 03/31/2005 | WO2005027951A1 Method for controlling angiogenesis in animals |
| 03/31/2005 | WO2005027945A1 Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same |
| 03/31/2005 | WO2005027941A1 Skin preparation for external use |
| 03/31/2005 | WO2005027940A1 Cataplasm for repairing damaged skin |
| 03/31/2005 | WO2005027933A1 Unsaturated phosphatidylcholines and uses thereof |
| 03/31/2005 | WO2005027904A1 Hair restorer |
| 03/31/2005 | WO2005027893A1 HUMAN β-DEFENSIN SECRETION PROMOTER |
| 03/31/2005 | WO2005027869A1 Use of oxygen in cosmetic or dermatological preparations |
| 03/31/2005 | WO2005027867A1 Anhydrous topical formulation for polyphenols |
| 03/31/2005 | WO2005027866A1 Use of licocalchone a or of an extract containing licocalchone a from radix glycyrrhizae inflatae against skin aging |
| 03/31/2005 | WO2005011565A3 Antimycosic nail varnish |
| 03/31/2005 | WO2005004894A3 Methods for increasing cell and tissue viability |
| 03/31/2005 | WO2004108133A3 Modulators of vr1 receptor |
| 03/31/2005 | WO2003040329A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 03/31/2005 | WO2003018756A3 Methods for preparing purified prostaglandin e synthase |
| 03/31/2005 | US20050070719 Central nervous system disorders; antidiabetic agents; antiinflammatory agents; antiarthritic agents;obesity; osteoporosis ; anticancer agents |
| 03/31/2005 | US20050070713 Neurokinin antagonist; therapy for central nervous system disorders; psychological disorders; Parkinson's and Huntington's disease |
| 03/31/2005 | US20050070706 Antidiabetic agents; obesity; controlling appetite |
| 03/31/2005 | US20050070694 Antagonistic anti-htnfsf13b human antibodies |
| 03/31/2005 | US20050070689 Nucleotide sequences coding transmembrane activator and CAML interactor (TACI) protein for use in treatment and prevention of autoimmune disorders |
| 03/31/2005 | US20050070610 Dermal compositions containing coenzyme q as the active ingredient |
| 03/31/2005 | US20050070590 possessing anti-cancer activity, anti-inflammatory activity, anti-obesity activity, and/or hair growth promotion activity |
| 03/31/2005 | US20050070574 Novel compounds |
| 03/31/2005 | US20050070572 Sulfone derivatives and their use in the treatment of autoimmune diseases and allergies |
| 03/31/2005 | US20050070569 Alkyne-aryl phosphodiesterase-4 inhibitors |
| 03/31/2005 | US20050070566 Imidazoquinoline derivatives |
| 03/31/2005 | US20050070559 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3 |
| 03/31/2005 | US20050070558 For example, [4-(2,4-Dioxo-1,3-dipropyl-2,3,4,5-tetrahydro-1H-pyrrolo[3,2-d]pyrimidin-6-yl)phenoxy]acetic acid; useful in preventing mast cell degranulation and therefore useful in treatment of diseases induced by activation of A2b receptor and mast cell activation such as asthma, allergic reactions |
| 03/31/2005 | US20050070555 Aroyl pyridinones |
| 03/31/2005 | US20050070535 Antidiabetic agents; obesity; controlling appetite |